Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

Panelists discuss how robust clinical evidence from major studies like the EPIC and OPERA trials demonstrates that ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into ...

For most people with MS, a cup or two a day is fine and may even help some symptoms like fatigue and cognitive function. But ...

NMC’s new regulations allow MSc-PhD holders to teach Pharmacology and Microbiology, treating them on par with MD/MS. Key ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

Find out how sNfL testing could transform MS care by predicting relapses early - explore the latest clinical insights now!

Kelsey Sharma, a nurse practitioner based in Minnesota, presents her research on the relationship between OSA, GERD, and IBD ...